Relevance and necessity of studies on second-line chemotherapy in melanoma.
Agarwala
Sanjiv S
SS
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003606:Dacarbazine / Q000627:therapeutic use*; D004317:Doxorubicin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D019317:Evidence-Based Medicine; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007376:Interleukin-2; D003606:Dacarbazine; D004317:Doxorubicin